Moody Lynn & Lieberson, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Moody Lynn & Lieberson, LLC

  • $1.54 Billion
  • Q3 2024

A detailed history of Moody Lynn & Lieberson, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Moody Lynn & Lieberson, LLC holds 267 shares of REGN stock, worth $187,393. This represents 0.02% of its overall portfolio holdings.

Number of Shares
267
Previous 1,022 73.87%
Holding current value
$187,393
Previous $1.07 Million 73.93%
% of portfolio
0.02%
Previous 0.07%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024
SELL
$1024.09 - $1201.76 $773,187 - $907,328
-755 Reduced 73.87%
267 $280,000
Q2 2024

Jul 25, 2024
SELL
$883.2 - $1071.19 $3.14 Million - $3.81 Million
-3,553 Reduced 77.66%
1,022 $1.07 Million
Q1 2024

Apr 23, 2024
BUY
$902.69 - $993.35 $49,647 - $54,634
55 Added 1.22%
4,575 $4.4 Million
Q4 2023

Jan 24, 2024
BUY
$775.18 - $881.7 $3.3 Million - $3.75 Million
4,253 Added 1592.88%
4,520 $3.97 Million
Q3 2023

Oct 24, 2023
BUY
$692.45 - $844.37 $184,884 - $225,446
267 New
267 $219,000
Q1 2023

May 02, 2023
SELL
$680.49 - $826.97 $2,721 - $3,307
-4 Reduced 0.09%
4,265 $3.5 Million
Q4 2022

Feb 01, 2023
SELL
$705.89 - $766.39 $3,529 - $3,831
-5 Reduced 0.12%
4,269 $3.08 Million
Q3 2022

Oct 26, 2022
SELL
$573.97 - $724.32 $1.94 Million - $2.45 Million
-3,387 Reduced 44.21%
4,274 $2.94 Million
Q2 2022

Jul 28, 2022
SELL
$548.35 - $738.84 $210,566 - $283,714
-384 Reduced 4.77%
7,661 $4.53 Million
Q1 2022

Apr 27, 2022
BUY
$595.12 - $698.43 $4.79 Million - $5.62 Million
8,045 New
8,045 $5.62 Million
Q4 2021

Jan 26, 2022
SELL
$543.48 - $670.97 $3.51 Million - $4.34 Million
-6,467 Closed
0 $0
Q3 2021

Oct 26, 2021
BUY
$574.03 - $680.96 $3.71 Million - $4.4 Million
6,467 New
6,467 $3.91 Million
Q3 2020

Oct 28, 2020
SELL
$544.75 - $658.21 $4.96 Million - $5.99 Million
-9,108 Closed
0 $0
Q2 2020

Jul 24, 2020
BUY
$493.32 - $643.92 $1.84 Million - $2.4 Million
3,721 Added 69.07%
9,108 $5.68 Million
Q1 2020

Apr 30, 2020
SELL
$336.18 - $494.43 $2.2 Million - $3.24 Million
-6,557 Reduced 54.9%
5,387 $2.63 Million
Q4 2019

Jan 28, 2020
BUY
$274.13 - $376.51 $3.27 Million - $4.5 Million
11,944 New
11,944 $4.49 Million

Others Institutions Holding REGN

# of Institutions
1,534
Shares Held
83.6M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $75.2B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Moody Lynn & Lieberson, LLC Portfolio

Follow Moody Lynn & Lieberson, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moody Lynn & Lieberson, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Moody Lynn & Lieberson, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email